Jayashri Mahalingam

748 total citations
10 papers, 518 citations indexed

About

Jayashri Mahalingam is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Jayashri Mahalingam has authored 10 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Jayashri Mahalingam's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers) and Immunotherapy and Immune Responses (4 papers). Jayashri Mahalingam is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (5 papers) and Immunotherapy and Immune Responses (4 papers). Jayashri Mahalingam collaborates with scholars based in Taiwan, India and United States. Jayashri Mahalingam's co-authors include Ching‐Tai Huang, Chun‐Yen Lin, Yu‐Yi Chu, Yung‐Chang Lin, Li-Yuan Chang, Jy‐Ming Chiang, Avijit Dutta, Chiao-Wen Kang, Yuan‐Ji Day and Tse‐Ching Chen and has published in prestigious journals such as PLoS ONE, Hepatology and Cancer Research.

In The Last Decade

Jayashri Mahalingam

10 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jayashri Mahalingam Taiwan 6 378 313 100 42 37 10 518
Caroline Imbert France 7 268 0.7× 278 0.9× 126 1.3× 39 0.9× 19 0.5× 19 468
Christian Quack Germany 3 497 1.3× 359 1.1× 86 0.9× 31 0.7× 27 0.7× 7 636
Cécile Déjou France 7 257 0.7× 180 0.6× 78 0.8× 33 0.8× 25 0.7× 9 415
Elise A. Mahé France 7 205 0.5× 213 0.7× 137 1.4× 39 0.9× 24 0.6× 8 379
Dmitrij Ostroumov Germany 5 294 0.8× 337 1.1× 137 1.4× 63 1.5× 25 0.7× 6 526
Zhubo Chen China 7 353 0.9× 193 0.6× 54 0.5× 27 0.6× 22 0.6× 8 474
Julia Cantón Spain 10 255 0.7× 186 0.6× 87 0.9× 35 0.8× 49 1.3× 20 390
Jeanne Galaine France 12 303 0.8× 298 1.0× 158 1.6× 58 1.4× 23 0.6× 28 512
Jimin Son South Korea 8 277 0.7× 209 0.7× 101 1.0× 55 1.3× 16 0.4× 14 438
Stephanie Mittman United States 6 377 1.0× 356 1.1× 90 0.9× 22 0.5× 18 0.5× 7 516

Countries citing papers authored by Jayashri Mahalingam

Since Specialization
Citations

This map shows the geographic impact of Jayashri Mahalingam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayashri Mahalingam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayashri Mahalingam more than expected).

Fields of papers citing papers by Jayashri Mahalingam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayashri Mahalingam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayashri Mahalingam. The network helps show where Jayashri Mahalingam may publish in the future.

Co-authorship network of co-authors of Jayashri Mahalingam

This figure shows the co-authorship network connecting the top 25 collaborators of Jayashri Mahalingam. A scholar is included among the top collaborators of Jayashri Mahalingam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayashri Mahalingam. Jayashri Mahalingam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Huang, Chien‐Hao, Jayashri Mahalingam, Tsung‐Han Wu, et al.. (2025). Tumor-migrating peripheral Foxp3-high regulatory T cells drive poor prognosis in HCC. Hepatology. 2 indexed citations
2.
Mahalingam, Jayashri, Shanthi Sabarimurugan, Muthu Thiruvengadam, et al.. (2021). Comparison of Cytokine Expression Profile in Chikungunya and Dengue Co-Infected and Mono-Infected Patients’ Samples. Pathogens. 10(2). 166–166. 5 indexed citations
3.
Sivasubramanian, Srinivasan, et al.. (2018). Leprosy-associated chronic wound management using biomaterials. Journal of Global Infectious Diseases. 10(2). 99–99. 4 indexed citations
4.
Yin, Chang Shik, Temesgen Fufa, Gayathri Chandrasekar, et al.. (2017). Phenotypic Screen Identifies a Small Molecule Modulating ERK2 and Promoting Stem Cell Proliferation. Frontiers in Pharmacology. 8. 726–726. 3 indexed citations
5.
Kang, Chiao-Wen, Avijit Dutta, Li-Yuan Chang, et al.. (2015). Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer. Scientific Reports. 5(1). 15659–15659. 136 indexed citations
6.
Chang, Li-Yuan, Yung‐Chang Lin, Jy‐Ming Chiang, et al.. (2015). Blockade of TNF-α signaling benefits cancer therapy by suppressing effector regulatory T cell expansion. OncoImmunology. 4(10). e1040215–e1040215. 48 indexed citations
7.
Mahalingam, Jayashri, Chun‐Yen Lin, Jy‐Ming Chiang, et al.. (2014). CD4+ T Cells Expressing Latency-Associated Peptide and Foxp3 Are an Activated Subgroup of Regulatory T Cells Enriched in Patients with Colorectal Cancer. PLoS ONE. 9(9). e108554–e108554. 28 indexed citations
8.
Mahalingam, Jayashri, Yung‐Chang Lin, Jy‐Ming Chiang, et al.. (2012). LAP+CD4+ T Cells Are Suppressors Accumulated in the Tumor Sites and Associated with the Progression of Colorectal Cancer. Clinical Cancer Research. 18(19). 5224–5233. 14 indexed citations
9.
Chang, Li-Yuan, Yung‐Chang Lin, Jayashri Mahalingam, et al.. (2012). Tumor-Derived Chemokine CCL5 Enhances TGF-β–Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells. Cancer Research. 72(5). 1092–1102. 189 indexed citations
10.
Lin, Yung‐Chang, Jayashri Mahalingam, Jy‐Ming Chiang, et al.. (2012). Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer. International Journal of Cancer. 132(6). 1341–1350. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026